Tackling the Diagnosis of Respiratory Infections During COVID-19 Using a Multiplex PCR Assay
About this webinar
Real-Time PCR Cycle Threshold (Ct) values have become a widely debated metric in the management of SARS-CoV-2 infection; however, their interpretive utility remains controversial. While Ct values may help augment the interpretation of a positive test, variability in clinical presentation and sample-related challenges necessitate that Ct values be framed within the context of the clinical presentation.
Join this webinar to hear Drs. Goldstein and Gendlina review this timely topic as well as scenarios, opportunities and limitations in the clinical utility of Ct values.
Who should attend
- Laboratory Managers
- Laboratory Directors
- Infectious Disease Physicians
- Internal Medicine Physicians
- Hospital Physicians
- Virologists
- Pathologists
- Pediatricians
- Microbiologists
- Antimicrobial stewardship committees
- Infection control committees
What you will learn
Join this webinar to understand how Ct values obtained from real-time PCR instrumentation have been implemented into clinical workflows and utilized in a diagnostic setting during the COVID-19 pandemic.
Featured Speakers
Dr. Yitz Goldstein, MD, FASCP
Dr. Yitz Goldstein attended the Albert Einstein College of Medicine and completed his residency in Anatomic and Clinical Pathology at Montefiore Medical Center. He went on to complete a molecular genetic pathology fellowship at the Mount Sinai School of Medicine. Dr. Goldstein is currently Assistant Professor of Pathology at the Albert Einstein College of Medicine and Director of Molecular Infectious disease testing and Director of the Molecular pathology laboratory at Montefiore Medical Center.
Dr. Inessa Gendlina, MD, PhD
Dr. Inessa Gendlina is a Board-certified Infectious Diseases physician and an assistant professor of Medicine at the Montefiore Albert Einstein College of Medicine. In addition to her medical degree, she holds a PhD in Microbiology. Since the pandemic, she serves as the content expert in Infectious Diseases and Infection Control/Epidemiology at the Montefiore Medical Center.
Partner for this event
QIAGEN
QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Further information can be found at https://www.qiagen.com.
Related webinars
More from QIAGEN.
Reduce Discovery Risk Using Comorbidity Data, Omics and Knowledge Graphs
Tumor Microenvironment Analysis Using Curated Data and Modeling
Leveraging Rapid Multiplex Testing During the Height of Respiratory Season
Liquid Biopsy Workflow Optimization for Improved Assay Sensitivity and Multianalyte Applications of Cell-Free RNA, DNA and CTCs
The Impact of Multiplex Testing for Respiratory Infections in North America
RNA Biomarker Development: From Sample to Insight
Exosome RNA for Biomarker Development
Revisiting the Central Dogma of Molecular Biology at the Genome Scale and in Single Cells
Total RNA Discovery: Studying Gene Expression One Transcript at a Time